12-109124475-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001093.4(ACACB):​c.-10+7771G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.529 in 152,032 control chromosomes in the GnomAD database, including 22,709 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 22709 hom., cov: 32)

Consequence

ACACB
NM_001093.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.943

Publications

9 publications found
Variant links:
Genes affected
ACACB (HGNC:85): (acetyl-CoA carboxylase beta) Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis. [provided by RefSeq, Oct 2022]
UNG (HGNC:12572): (uracil DNA glycosylase) This gene encodes one of several uracil-DNA glycosylases. One important function of uracil-DNA glycosylases is to prevent mutagenesis by eliminating uracil from DNA molecules by cleaving the N-glycosylic bond and initiating the base-excision repair (BER) pathway. Uracil bases occur from cytosine deamination or misincorporation of dUMP residues. Alternative promoter usage and splicing of this gene leads to two different isoforms: the mitochondrial UNG1 and the nuclear UNG2. The UNG2 term was used as a previous symbol for the CCNO gene (GeneID 10309), which has been confused with this gene, in the literature and some databases. [provided by RefSeq, Nov 2010]
UNG Gene-Disease associations (from GenCC):
  • hyper-IgM syndrome type 5
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.727 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACACBNM_001093.4 linkc.-10+7771G>T intron_variant Intron 1 of 52 ENST00000338432.12 NP_001084.3 O00763-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACACBENST00000338432.12 linkc.-10+7771G>T intron_variant Intron 1 of 52 1 NM_001093.4 ENSP00000341044.7 O00763-1
UNGENST00000699563.1 linkc.775-1470G>T intron_variant Intron 5 of 5 ENSP00000514437.1 A0A8V8TNE1
ENSG00000256139ENST00000541704.2 linkn.577-786G>T intron_variant Intron 2 of 2 5
ENSG00000256139ENST00000755021.1 linkn.*185G>T downstream_gene_variant

Frequencies

GnomAD3 genomes
AF:
0.528
AC:
80279
AN:
151912
Hom.:
22673
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.734
Gnomad AMI
AF:
0.325
Gnomad AMR
AF:
0.442
Gnomad ASJ
AF:
0.464
Gnomad EAS
AF:
0.701
Gnomad SAS
AF:
0.506
Gnomad FIN
AF:
0.495
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.424
Gnomad OTH
AF:
0.503
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.529
AC:
80369
AN:
152032
Hom.:
22709
Cov.:
32
AF XY:
0.531
AC XY:
39431
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.734
AC:
30428
AN:
41476
American (AMR)
AF:
0.442
AC:
6750
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.464
AC:
1610
AN:
3470
East Asian (EAS)
AF:
0.701
AC:
3627
AN:
5174
South Asian (SAS)
AF:
0.505
AC:
2439
AN:
4828
European-Finnish (FIN)
AF:
0.495
AC:
5225
AN:
10552
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.424
AC:
28813
AN:
67930
Other (OTH)
AF:
0.506
AC:
1067
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1853
3706
5560
7413
9266
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.437
Hom.:
7980
Bravo
AF:
0.529
Asia WGS
AF:
0.606
AC:
2109
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.11
DANN
Benign
0.67
PhyloP100
-0.94
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2430682; hg19: chr12-109562280; API